NCT06959745View on ClinicalTrials.gov

Magnesium-L-Threonate Improves Menopausal Symptoms

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 30, 2025

Conditions
Menopause SyndromeMagnesium
Interventions
DRUG

Magnesium-L-Threonate

Magnesium L-threonate, 1740 mg, taken orally, twice a day, for 8 weeks.

DRUG

Placebo

Placebo, 1740 mg, taken orally, twice a day, for 8 weeks.

Trial Locations (1)

Unknown

Global Health Research Center,Guangdong Provincial People's Hospital(Guanadong Academy of Medical Sciences), Guangzhou

All Listed Sponsors
lead

Guangdong Provincial People's Hospital

OTHER

NCT06959745 - Magnesium-L-Threonate Improves Menopausal Symptoms | Biotech Hunter | Biotech Hunter